Orion Pharma Ltd.

Last week’s J.P. Morgan Healthcare Conference in San Francisco generated multiple headlines for the generics and biosimilars industry, with Generics Bulletin bringing you dedicated stories on the la

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Regeneron Bolsters Ophthalmic Portfoli

Cash-strapped Alligator Biosciences is reducing its workforce and early-stage activities to put all its focus on preparing its pancreatic cancer candidate, mitazalimab, for Phase III trials. The Swedi

The Nordic region is punching well above its weight in terms of pipeline size, numbers of companies and clinical trials as well as fundraising activities, and the future for firms in Iceland, Finland